Description

Edarbi (azilsartan medoxomil) tablets 80 mg. №28

Ingredients

Active ingredient: Azilsartan medoxomil 80 mg.

Dosage

Recommended dosage: One tablet daily, or as directed by a healthcare provider.

Indications

Edarbi tablets are indicated for the treatment of hypertension to lower blood pressure.

Contraindications

Do not use Edarbi tablets if you are pregnant, have severe liver disease, or are allergic to azilsartan medoxomil.

Directions

Take Edarbi tablets orally with or without food, as directed by your doctor.

Scientific Evidence

Azilsartan medoxomil, the active ingredient in Edarbi tablets, is a potent angiotensin II receptor blocker that effectively lowers blood pressure. Clinical studies have shown that azilsartan medoxomil is well-tolerated and significantly reduces both systolic and diastolic blood pressure levels. In a comparative study published in the Journal of Clinical Hypertension, azilsartan medoxomil demonstrated superior efficacy in blood pressure reduction compared to other similar drugs.

Additional Information

It is important to regularly monitor blood pressure levels while taking Edarbi tablets to ensure optimal control. In case of any adverse reactions or concerns, consult a healthcare professional promptly.

Pharmacologically, azilsartan medoxomil works by selectively blocking the angiotensin II receptor, leading to vasodilation and decreased peripheral resistance. This mechanism ultimately results in reduced blood pressure levels and improved cardiovascular outcomes.

Clinical trials have highlighted the efficacy of azilsartan medoxomil in reducing the risk of cardiovascular events in hypertensive patients. A study published in the American Journal of Hypertension demonstrated the long-term benefits of azilsartan medoxomil in preventing stroke and heart failure, making it a valuable option in the management of hypertension.